(Q59558371)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

review article

1 reference

title

Human immunodeficiency virus infection in children (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

author name string

J Falloon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

J Eddy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

P A Pizzo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

language of work or name

English

0 references

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

2 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

page(s)

1-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

Immune deficiency syndrome in children

2 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Acquired immunodeficiency syndrome in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Unexplained immunodeficiency in children. A surveillance report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

The epidemiology of pediatric acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Unrecognized modes of transmission of HIV: acquired immunodeficiency syndrome in children reported without risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Acquired immunodeficiency in an infant: possible transmission by means of blood products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Transfusion-associated acquired immune deficiency syndrome in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Immunologic dysfunction in infants infected through transfusion with HTLV-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Transmission of the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Epidemiology of AIDS in women in the United States. 1981 through 1986.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

LAV/HTLV-III in 20-week fetus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Vertical transmission of HIV in 15-week fetus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Transplacental transmission of HTLV-III virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Human T-cell lymphotropic virus type III (HTLV-III) embryopathy. A new dysmorphic syndrome associated with intrauterine HTLV-III infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Fetal AIDS syndrome score. Correlation between severity of dysmorphism and age at diagnosis of immunodeficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Lack of evidence for craniofacial dysmorphism in perinatal human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Postnatal transmission of AIDS-associated retrovirus from mother to infant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Postnatal transmission of HIV from mother to child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Vertical transmission of HTLV-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Transmission of HTLV-III infection by heterosexual contact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Infants born to mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicentre European study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Evidence against transmission of human T-lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) in families of children with the acquired immunodeficiency syndrome.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

7 January 2021

Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

AIDS and antibodies to human immunodeficiency virus (HIV) in children and their families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Evaluation of heterosexual partners, children, and household contacts of adults with AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Horizontal transmission of HIV infection between two siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Licensed tests for antibody to human T-lymphotropic virus type III. Sensitivity and specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Testing for human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Perinatal infection with human immunodeficiency virus. Specific antibody responses by the neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Specific antibody and virus antigen expression in congenital HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Early detection of HIV infection in a newborn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Detecting human immunodeficiency virus RNA in peripheral blood mononuclear cells by nucleic acid hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Laboratory investigation of pediatric acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Transplacental transmission of human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Delayed and defective anti-HIV IgM response in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Early diagnosis of HIV infection in the neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

IN-VITRO PRODUCTION OF HIV-SPECIFIC ANTIBODY IN CHILDREN AT RISK OF AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Prematurity, hypogammaglobulinemia, and neuropathology with human immunodeficiency virus (HIV) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Isolation of human immunodeficiency virus and detection of HIV DNA sequences in the brain of an ELISA antibody-negative child with acquired immune deficiency syndrome and progressive encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Human-immunodeficiency-virus infections in infants negative for anti-HIV by enzyme-linked immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Toxoplasma encephalitis in an infant with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pediatric acquired immune deficiency syndrome with panhypogammaglobulinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Delayed appearance of HIV infection in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Antibodies to AIDS-associated retrovirus distinguish between pediatric primary and acquired immunodeficiency diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Human immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

A human T-lymphotropic retrovirus (HTLV-III) as the cause of the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pathogenesis of infection with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

The HIV 'A' (sor) gene product is essential for virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Immunopathogenesis of the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Immunologic abnormalities in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

The role of mononuclear phagocytes in HTLV-III/LAV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Infection of monocyte/macrophages by human T lymphotropic virus type III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Factors associated with the pathogenesis of AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Circulating thymulin and thymosin-alpha 1 activity in pediatric acquired immune deficiency syndrome: in vivo and in vitro studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Antibody responses to bacterial toxoids in children infected with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

IgG subglass deficiencies in children with suspected AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Longitudinal study of 18 children with perinatal LAV/HTLV III infection: attempt at prognostic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Neutralization of HTLV-III/LAV replication by antiserum to thymosin alpha 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Low circulating thymulin-like activity in children with AIDS and AIDS-related complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Acquired immune deficiency syndrome in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Prolonged survival and late presentation of vertically transmitted HIV infection in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Incubation period of AIDS in patients infected via blood transfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Prevention of pneumococcal bacteremia in a child with acquired immunodeficiency syndrome-related complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Neurological complications in infants and children with acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Progressive encephalopathy in children with acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Developmental abnormalities in children with acquired immunodeficiency syndrome (AIDS): a follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pediatric acquired immunodeficiency syndrome. Neurologic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

AIDS: calcification of the basal ganglia in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

HTLV-III infection in brains of children and adults with AIDS encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Expression of human immunodeficiency virus in cerebrospinal fluid of children with progressive encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: a study of ten cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pulmonary lesions in children with the acquired immunodeficiency syndrome: A reappraisal based on data in additional cases and follow-up study of previously reported cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pulmonary disease in children with acquired immune deficiency syndrome and AIDS-related complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Detection of HTLV-III/LAV-specific IgG and antigen in bronchoalveolar lavage fluid from two patients with lymphocytic interstitial pneumonitis associated with AIDS-related complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pathology of opportunistic infections in children with acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Infection with two genotypes of Epstein-Barr virus in an infant with AIDS and lymphoma of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Kaposi sarcoma in two infants with acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Polyclonal polymorphic B-cell lymphoproliferative disorder with prominent pulmonary involvement in children with acquired immune deficiency syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Pathology of suspected acquired immune deficiency syndrome in children: a study of eight cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

The types of renal disease in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Perivasculitis of the retinal vessels as an important sign in children with AIDS-related complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Thrombocytopenia as the presenting manifestation of human T-lymphotropic virus type III infection in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Severe neutropenia associated with anti-neutrophil antibody in a patient with acquired immunodeficiency syndrome-related complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Circulating coagulation inhibitors in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Primary human T-lymphotropic virus type III infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Acute encephalopathy coincident with seroconversion for anti-HTLV-III.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Life table analysis of children with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Serum lactate dehydrogenase levels in adults and children with acquired immune deficiency syndrome (AIDS) and AIDS-related complex: possible indicator of B cell lymphoproliferation and disease activity. Effect of intravenous gammaglobulin on enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Intravenous immunoglobulin in the treatment and prevention of acute infections in pediatric acquired immunodeficiency syndrome patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Treatment of patients with acquired immunodeficiency syndrome and associated manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Treatment of infections in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Developmental therapeutics and the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Treatable aspects of infection due to human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Cryptosporidium and cryptosporidiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Cryptosporidium and Isospora belli infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

AIDS commentary. Toxoplasmic encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Cryptococcosis in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Syphilis and infection with the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Coccidioidomycosis in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Histoplasmosis in the acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Mycobacterioses and the acquired immunodeficiency syndrome. Joint Position Paper of the American Thoracic Society and the Centers for Disease Control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Strategies for antiviral therapy in AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Ribavirin in HTLV-III/LAV infection of infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Azidothymidine neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Significant changes in HIV antigen level in the serum of patients treated with azidothymidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Immunologic reconstitution in the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Treatment of the acquired immune deficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

The prospects for and pathways toward a vaccine for AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Immunization against AIDS in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

The prevention of acquired immunodeficiency syndrome in the United States. An objective strategy for medicine, public health, business, and the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

Neurologic manifestations of AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

7 January 2021

Salmonellosis during infection with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

7 January 2021

Use of trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonitis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

7 January 2021

Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980596-7

7 January 2021

10.1016/S0022-3476(89)80596-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2642548%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

1 reference